Prevalence of interstitial pneumonia suggestive of COVID-19 at


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
08 2021
Historique:
received: 15 12 2020
accepted: 24 01 2021
pubmed: 10 2 2021
medline: 14 7 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

To assess the presence and pattern of incidental interstitial lung alterations suspicious of COVID-19 on fluorine-18-fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT) ([ This is a multi-center retrospective observational study involving 59 Italian centers. We retrospectively reviewed the prevalence of interstitial pneumonia detected during the COVID period (between March 16 and 27, 2020) and compared to a pre-COVID period (January-February 2020) and a control time (in 2019). The diagnosis of interstitial pneumonia was done considering lung alterations of CT of PET. Overall, [ A significant increase of interstitial pneumonia incidentally detected with [

Identifiants

pubmed: 33560453
doi: 10.1007/s00259-021-05219-0
pii: 10.1007/s00259-021-05219-0
pmc: PMC7871520
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2871-2882

Investigateurs

M Bonacina (M)
R Laudicella (R)
M Spallino (M)
A Palucci (A)
M Cuzzocrea (M)
M Donner (M)
S Maurea (S)
F Ceci (F)
F Dei Rossi (F)
B Tranfaglia (B)
A Sartorello (A)
P Gandolfo (P)
A Buschiazzo (A)
A Scarale (A)
M Kirienko (M)
N Merenda (N)
A G Nappi (AG)
R Durmo (R)
C Vellani (C)
V Ceriani (V)

Références

Park M, Thwaites RS, Openshaw PJM. COVID-19: lessons from SARS and MERS. Eur J Immunol. 2020;50(3):308–11.
doi: 10.1002/eji.202070035
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
doi: 10.1016/S0140-6736(20)30183-5
Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020. https://doi.org/10.1001/jama.2020.2783 .
Kanne JP, Little BP, Chung JH, et al. Essentials for radiologists on COVID-19: an update radiology scientific expert panel. Radiology. 2020;295(1):16–7.
doi: 10.1148/radiol.2020200241
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30086-4 .
EYP L, Ng MY, Khong PL. COVID-19 pneumonia: what has CT taught us. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30134-1 .
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 bovel coronavirus (2019-nCoV). Radiology. 2020:200230. https://doi.org/10.1148/radiol.2020200230 .
Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296:E115–7. https://doi.org/10.1148/radiol.2020200432 .
doi: 10.1148/radiol.2020200432
Xie X, Zhong Z, Zhao W, et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020. https://doi.org/10.1148/radiol.2020200343 .
Albano D, Bertagna F, Bertoli M, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med. 2020;61:632–6.
doi: 10.2967/jnumed.120.246256
Setti L, Kirienko M, Dalto SM, et al. FDG-PET/CT findings highly suspicious for COVID-19 in an Italian case series of asymptomatic patients. Eur J Nucl Med Mol Imaging. 2020;47:1649–56.
doi: 10.1007/s00259-020-04819-6
Colandrea M, Gilardi L, Travaini LL, et al.
doi: 10.1007/s11604-020-01006-3
Scarlattei M, Baldari G, Silva M, et al. Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer. Tumori. 2020;106:325–32.
doi: 10.1177/0300891620935983
Polverari G, Arena V, Ceci F, et al. 18 F-Fluorodeoxyglucose uptake in patient with asymptomatic severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) referred to positron emission tomography/computed tomography for NSCLC restaging. J Thoracic Oncol. 2020;15:1078–80.
doi: 10.1016/j.jtho.2020.03.022
Albano D, Camoni L, Rinaldi R, et al.
doi: 10.1097/RLU.0000000000003150
Maurea S, Mainolfi CG, Bombace C, et al. FDG-PET/CT imaging during the Covid-19 emergency: a southern Italian perspective. Eur J Nucl Med Mol Imaging. 2020;47:2691–7.
doi: 10.1007/s00259-020-04931-7
Setti L, Bonacina M, Meroni R, et al. Increased incidence of interstitial pneumonia detected on [18F]-FDG-PET/CT in asymptomatic cancer patients during COVID-19 pandemic in Lombardy: a casualty or COVID-19 infection? Eur J Nucl Med Mol Imaging. 2020. https://doi.org/10.1007/s00259-020-05027-y .
Pallardy A, Rousseau C, Labbe, et al. Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing
Halsey R, Priftakis D, Mackenzie S, et al. COVID-19 in the act: incidental
Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181–200.
doi: 10.1007/s00259-009-1297-4
Hani C, Trieu NH, Saab I, et al. COVID-19 pneumonia: a review of typical CT findings and differential diagnosis. Diagn Interv Imaging. 2020;101:263–8.
doi: 10.1016/j.diii.2020.03.014
Ye Z, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020;30:4381–9.
doi: 10.1007/s00330-020-06801-0
Han R, Huang L, Jiang H, et al. Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. AJR Am J Roentgenol. 2020;215:338–43.
doi: 10.2214/AJR.20.22961
Bao C, Liu X, Zhang H, et al. Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis. J Am Coll Radiol. 2020;17:701–9.
doi: 10.1016/j.jacr.2020.03.006
Treglia G. The role of
doi: 10.1007/s40336-020-00367-z
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.
doi: 10.1016/S0140-6736(20)30566-3
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–7.
doi: 10.1111/jth.14768
McGonagle D, Sharif K, O'Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19:102537.
doi: 10.1016/j.autrev.2020.102537
Annunziata S, Delgado Bolton RC, Kamani CE, et al. Role of 2-[
doi: 10.3390/ph13110377
Annunziata S, Bauckneht M, Albano D, et al. Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey. Eur J Nucl Med Mol Imaging. 2020;47:2090–9.
doi: 10.1007/s00259-020-04874-z
Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296:E32–49.
doi: 10.1148/radiol.2020200642

Auteurs

Domenico Albano (D)

Nuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy. domenico.albano@unibs.it.

Francesco Bertagna (F)

Nuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy.

Pierpaolo Alongi (P)

Unit of Nuclear Medicine, Fondazione Istituto G.Giglio, 90015, Cefalù, Italy.

Sergio Baldari (S)

Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, 98125, Messina, Italy.

Alfonso Baldoncini (A)

Nuclear Medicine Department, Ospedale San Donato, Arezzo, Italy.

Mirco Bartolomei (M)

Nuclear Medicine Department, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.

Franco Boccaletto (F)

Nuclear Medicine Department, Treviso Hospital, Treviso, Italy.

Michele Boero (M)

Nuclear Medicine Unit, ARNAS G. Brotzu, Cagliari, Italy.

Eugenio Borsatti (E)

Nuclear Medicine, IRCCS CRO, Aviano, Italy.

Andrea Bruno (A)

Department of Nuclear Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy.

Luca Burroni (L)

Department of Nuclear Medicine, "Ospedali Riuniti di Torrette" Hospital, Ancona, Italy.

Francesca Capoccetti (F)

Service Department Macerata Hospital, ASUR Marche AV3, Nuclear Medicine Unit, Macerata, Italy.

Massimo Castellani (M)

Nuclear Medicine Department, Fondazione IRCCS Cà Grande Ospedale Maggiore Policlinico, Milan, Italy.

Anna Rita Cervino (AR)

Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Franca Chierichetti (F)

Nuclear Medicine, S. Chiara Hospital, Trento, Italy.

Andrea Ciarmiello (A)

Nuclear Medicine Unit, S. Andrea Hospital, La Spezia, Italy.

Angelo Corso (A)

Department of Nuclear Medicine, Sant'Anna Hospital, Como, Italy.

Alberto Cuocolo (A)

Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.

Maria Luisa De Rimini (ML)

Nuclear Medicine Unit, AO Ospedali Dei Colli, Monaldi Hospital, Naples, Italy.

Desiree' Deandreis (D)

Division of Nuclear Medicine, Department of Medical Sciences, University of Turin, AOU Città della Salute e della Scienza, 10126, Turin, Italy.

Massimo Eugenio Dottorini (ME)

Department of Diagnostic Imaging, Nuclear Medicine Unit, Ospedale "S. Maria della Misericordia", Perugia, Italy.

Filomena Esposito (F)

Nuclear Medicine, Neuromed, Pozzilli, Italy.

Mohsen Farsad (M)

Nuclear Medicine, Central Hospital Bolzano, Bolzano, Italy.

Massimo Gasparini (M)

Department of Nuclear Medicine, IRCCS MultiMedica Sesto San Giovanni, Milan, Italy.

Chiara Maria Grana (CM)

Division of Nuclear Medicine, European Institute of Oncology, IRCCS, Milan, Italy.

Michele Gregianin (M)

Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto, Italy.

Luca Guerra (L)

Nuclear Medicine, University of Milan Bicocca and ASST Ospedale San Gerardo, Monza, Italy.

Fabio Loreti (F)

Nuclear Medicine Unit, S. Maria Hospital, Terni, Italy.

Andrea Lupi (A)

Division of Nuclear Medicine, Ospedale S. Bortolo, Vicenza, Italy.

Gianluigi Martino (G)

Unit of Nuclear Medicine, Department of Radiology and Clinical Radiotherapy, SS Annunziata Hospital, Chieti, Italy.

Elisa Milan (E)

Nuclear Medicine Department, Treviso Hospital, Treviso, Italy.

Sergio Modoni (S)

Nuclear Medicine Department, University Hospital Ospedali Riuniti, Foggia, Italy.

Silvia Morbelli (S)

IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Department of Health Science (DISSAL), University of Genoa, Genoa, Italy.

Alfredo Muni (A)

Nuclear Medicine Department, Azienda Ospedaliera S.S. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.

Emanuele Nicolai (E)

IRCCS SDN, Naples, Italy.

Barbara Palumbo (B)

Department of Diagnostic Imaging, Nuclear Medicine Unit, Ospedale "S. Maria della Misericordia", Perugia, Italy.
Section of Nuclear Medicine and Health Physics, Department of Medicine and Surgery-University of Perugia, Perugia, Italy.

Sergio Papa (S)

Unit of Diagnostic Imaging and Stereotactic Radiosurgery, CDI Centro Diagnostico Italiano,, Via Saint Bon 20, 20147, Milan, Italy.

Alberto Papaleo (A)

Nuclear Medicine Department, S. Croce e Carle Hospital Cuneo, Cuneo, Italy.

Riccardo Pellerito (R)

Department of Nuclear Medicine, Mauriziano Hospital, Turin, Italy.

Carlo Poti (C)

Unit of Nuclear Medicine, Aosta Regional Hospital, Aosta, Italy.

Pasquale Romano (P)

Department of Nuclear Medicine, Studio Radiologico Guidonia, Guidonia, Italy.

Claudio Rossetti (C)

Nuclear Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Pierluigi Rossini (P)

Nuclear Medicine, Azienda Socio Sanitaria Territoriale di Mantova. Ospedale C. Poma, Mantova, Italy.

Giuseppe Rubini (G)

Nuclear Medicine Unit, Department of Interdisciplinary Medicine, AOU Policlinico, University of Bari, Bari, Italy.

Livia Ruffini (L)

Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

Gianmauro Sacchetti (G)

Nuclear Medicine Department, AOU Maggiore della Carità, Novara, Italy.

Giordano Savelli (G)

Nuclear Medicine Department, Fondazione Poliambulanza, Brescia, Italy.

Saverio Schiavariello (S)

Nuclear Medicine Unit, ASM Matera, Matera, Italy.

Roberto Sciagrà (R)

Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

Rosa Sciuto (R)

Nuclear Medicine Unit, IRCCS-Regina Elena National Cancer Institute, 00144, Rome, Italy.

Ettore Seregni (E)

Division of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Stelvio Sestini (S)

Unit of Nuclear Medicine, Department of Diagnostic Imaging, N.O.P. - S. Stefano, U.S.L. Toscana Centro, Prato, Italy.

Michele Sicolo (M)

Nuclear Medicine Unit, Dell'Angelo Hospital, Mestre-Venezia, Italy.

Angela Spanu (A)

Nuclear Medicine Unit, Department of Medical, Surgical and Experimental sciences, University of Sassari, Sassari, Italy.

Giovanni Storto (G)

Nuclear Medicine Department, IRCCS CROB, Referral Cancer Center of Basilicata, 85028, Rionero in Vulture, Italy.

Massimo Tosti Balducci (MT)

Nuclear Medicine Department, Azienda Usl Toscana sud est, Arezzo, Italy.

Giuseppe Trifirò (G)

Nuclear Medicine Department, ICS Maugeri SpA SB-IRCCS, Pavia, Italy.

Annibale Versari (A)

Nuclear Medicine Unit, Azienda AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Alberto Vignati (A)

Nuclear Medicine Department, ASST Ovest Milanese, Legnano, Italy.

Duccio Volterrani (D)

Regional Center of Nuclear Medicine, University Hospital of Pisa, Pisa, Italy.

Maria Lucia Calcagni (ML)

Istituto di Medicina Nucleare, Università Cattolica del Sacro Cuore, & UOC di Medicina Nucleare, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, L.go Agostino Gemelli 8, 00168, Rome, Italy.

Maria Cristina Marzola (MC)

Department of Nuclear Medicine PET/CT Centre, S. Maria della Misericordia Hospital, 45100, Rovigo, Italy.

Antonio Garufo (A)

Nuclear Medicine Department, ASP Agrigento, Agrigento, Italy.

Laura Evangelista (L)

Nuclear Medicine Unit, Department of Medicine-DIMED, University of Padova, 35128, Padova, Italy.

Roberto Maroldi (R)

Department of Radiology, University of Brescia, ASST Spedali Civili Brescia, Brescia, Italy.

Orazio Schillaci (O)

Department of Biomedicine and Prevention, Tor Vergata University Hospital, Rome, Italy.

Raffaele Giubbini (R)

Nuclear Medicine, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH